GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » EV-to-Revenue

Kindstar Globalgene Technology (HKSE:09960) EV-to-Revenue : -0.15 (As of Dec. 15, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Kindstar Globalgene Technology EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Kindstar Globalgene Technology's enterprise value is HK$-155 Mil. Kindstar Globalgene Technology's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was HK$1,029 Mil. Therefore, Kindstar Globalgene Technology's EV-to-Revenue for today is -0.15.

The historical rank and industry rank for Kindstar Globalgene Technology's EV-to-Revenue or its related term are showing as below:

HKSE:09960' s EV-to-Revenue Range Over the Past 10 Years
Min: -1.58   Med: -0.47   Max: 6.79
Current: -0.14

During the past 6 years, the highest EV-to-Revenue of Kindstar Globalgene Technology was 6.79. The lowest was -1.58. And the median was -0.47.

HKSE:09960's EV-to-Revenue is ranked better than
97.7% of 217 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.01 vs HKSE:09960: -0.14

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-12-15), Kindstar Globalgene Technology's stock price is HK$1.14. Kindstar Globalgene Technology's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$1.07. Therefore, Kindstar Globalgene Technology's PS Ratio for today is 1.07.


Kindstar Globalgene Technology EV-to-Revenue Historical Data

The historical data trend for Kindstar Globalgene Technology's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindstar Globalgene Technology EV-to-Revenue Chart

Kindstar Globalgene Technology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - - 2.25 0.45 -0.30

Kindstar Globalgene Technology Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 0.45 - -0.30 -

Competitive Comparison of Kindstar Globalgene Technology's EV-to-Revenue

For the Diagnostics & Research subindustry, Kindstar Globalgene Technology's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kindstar Globalgene Technology's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Kindstar Globalgene Technology's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Kindstar Globalgene Technology's EV-to-Revenue falls into.



Kindstar Globalgene Technology EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Kindstar Globalgene Technology's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=-154.820/1028.564
=-0.15

Kindstar Globalgene Technology's current Enterprise Value is HK$-155 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kindstar Globalgene Technology's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was HK$1,029 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kindstar Globalgene Technology  (HKSE:09960) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Kindstar Globalgene Technology's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=1.14/1.066
=1.07

Kindstar Globalgene Technology's share price for today is HK$1.14.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2024 was HK$1.07.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kindstar Globalgene Technology EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Kindstar Globalgene Technology Business Description

Traded in Other Exchanges
N/A
Address
Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN
Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services in China. It organizes the business into the following segments; hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, scientific research services and CRO, and other segments provide testing services for R&D projects and others and miscellaneous services.
Executives
Jackson Hole Trust Company
Huang Bo
Kernelstar Limited 2301 Trustee
Kastle Limited 2301 Trustee
Guo Gui-rong 2202 Interest of your spouse
Huang Shiang 2101 Beneficial owner
Huang Zuie-chin 2101 Beneficial owner
Tu Zanbing
Chan Tan Ching Fen 2307 Founder of a discretionary trust who can infl
Ningbo Meishan Bonded Port Zone Ruifu Bojian Investment Management Co., Ltd.
Cpechina Fund Iii, L.p. 2201 Interest of corporation controlled by you
Cpe Holdings Limited 2201 Interest of corporation controlled by you
Cpe Holdings International Limited 2201 Interest of corporation controlled by you
Cpe Funds Iii Limited 2201 Interest of corporation controlled by you
Ck Lab Tech Investment Limited 2101 Beneficial owner

Kindstar Globalgene Technology Headlines

No Headlines